Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Haidong Yang, Wen Pan, Wenhuan Xiao, Man Yang, Jianchun Xu, Jin Li & Xiaobin Zhang. (2022) Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms. BMC Psychiatry 22:1.
Crossref
Crossref
Jeffrey Fessel. (2022) Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients. Translational Psychiatry 12:1.
Crossref
Crossref
Haidong Yang, Wenhuan Xiao, Man Yang, Yili Wang & Xiaobin Zhang. (2021) Decreased neuregulin1β1 in first episode and drug-naïve patients with schizophrenia: Negative correlation with cognitive impairment. Psychiatry Research 304, pages 114164.
Crossref
Crossref
Peng Chen, Hongyang Jing, Mingtao Xiong, Qian Zhang, Dong Lin, Dongyan Ren, Shunqi Wang, Dongmin Yin, Yongjun Chen, Tian Zhou, Baoming Li, Erkang Fei & Bing-Xing Pan. (2021) Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation. Cell Death & Disease 12:4.
Crossref
Crossref
Yao-Yi Wang, Bing Zhao, Meng-Meng Wu, Xiao-Li Zheng, Longnian Lin & Dong-Min Yin. (2021) Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition. Nature Communications 12:1.
Crossref
Crossref
Ashwini Rajasekaran, Venkataram Shivakumar, Sunil V. Kalmady, Rujuta Parlikar, Harleen Chhabra, Ananya Prabhu, Manjula Subbanna, Deepthi Venugopal, Anekal C. Amaresha, Sri Mahavir Agarwal, Anushree Bose, Janardhanan C. Narayanaswamy, Monojit Debnath & Ganesan Venkatasubramanian. (2020) Impact of NRG1 HapICE gene variants on digit ratio and dermatoglyphic measures in schizophrenia. Asian Journal of Psychiatry 54, pages 102363.
Crossref
Crossref
Inga H. Deakin, Beata R. Godlewska, Mary A. Walker, Guo-Jen Huang, Markus H. Schwab, Klaus-Armin Nave, Amanda J. Law & Paul J. Harrison. (2018) Altered hippocampal gene expression and structure in transgenic mice overexpressing neuregulin 1 (Nrg1) type I. Translational Psychiatry 8:1.
Crossref
Crossref
Alireza Mohammadi, Ehsan Rashidi & Vahid Ghasem Amooeian. (2018) Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Research 265, pages 25-38.
Crossref
Crossref
Dimitrios Kotzadimitriou, Wiebke Nissen, Melinda Paizs, Kathryn Newton, Paul J. Harrison, Ole Paulsen & Karri Lamsa. (2018) Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor–Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK. eneuro 5:2, pages ENEURO.0418-17.2018.
Crossref
Crossref
Dimitrios Avramopoulos. (2018) Neuregulin 3 and its roles in schizophrenia risk and presentation. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177:2, pages 257-266.
Crossref
Crossref
Md Shaki Mostaid, Ting Ting Lee, Gursharan Chana, Suresh Sundram, Cynthia Shannon Weickert, Christos Pantelis, Ian Everall & Chad Bousman. (2017) Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients. Translational Psychiatry 7:12.
Crossref
Crossref
Colm M P O'Tuathaigh, Paula M Moran, Xuechu C Zhen & John L Waddington. (2017) Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. British Journal of Pharmacology 174:19, pages 3173-3190.
Crossref
Crossref
Colm M. P O’Tuathaigh, Naina Mathur, Matthew J O’Callaghan, Lynsey MacIntyre, Richard Harvey, Donna Lai, John L Waddington, Benjamin S Pickard, David G Watson & Paula M Moran. (2017) Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1. Schizophrenia Bulletin 43:5, pages 1100-1113.
Crossref
Crossref
Manveen K. Sethi & Joseph Zaia. (2016) Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease. Analytical and Bioanalytical Chemistry 409:2, pages 379-394.
Crossref
Crossref
Md Shaki Mostaid, David Lloyd, Benny Liberg, Suresh Sundram, Avril Pereira, Christos Pantelis, Tim Karl, Cynthia Shannon Weickert, Ian P. Everall & Chad A. Bousman. (2016) Neuregulin-1 and schizophrenia in the genome-wide association study era. Neuroscience & Biobehavioral Reviews 68, pages 387-409.
Crossref
Crossref
Lieve Desbonnet. 2016. Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior. Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior
267
284
.
John L. Waddington & Colm M. P. O’Tuathaigh. 2015. Drug Discovery for Schizophrenia. Drug Discovery for Schizophrenia
89
114
.
John P. John, Priyadarshini Thirunavukkarasu, Harsha N. Halahalli, Meera Purushottam & Sanjeev Jain. (2015) A systematic review of the effect of genes mediating neurodevelopment and neurotransmission on brain morphology: Focus on schizophrenia. Neurology, Psychiatry and Brain Research 21:1, pages 1-26.
Crossref
Crossref
Chao Deng, Bo Pan, Chang-Hua Hu, Mei Han & Xu-Feng Huang. (2015) Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain. Psychiatry Research 225:3, pages 347-354.
Crossref
Crossref
Gregg W. Crabtree & Joseph A. Gogos. (2014) Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Frontiers in Synaptic Neuroscience 6.
Crossref
Crossref
Tariq W. Chohan, Aurelie A. Boucher, Jarrah R. Spencer, Mustafa S. Kassem, Areeg A. Hamdi, Tim Karl, Sandra Y. Fok, Maxwell R. Bennett & Jonathon C. Arnold. (2014) Partial Genetic Deletion of Neuregulin 1 Modulates the Effects of Stress on Sensorimotor Gating, Dendritic Morphology, and HPA Axis Activity in Adolescent Mice. Schizophrenia Bulletin 40:6, pages 1272-1284.
Crossref
Crossref
Lin Mei & Klaus-Armin Nave. (2014) Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases. Neuron 83:1, pages 27-49.
Crossref
Crossref
Ju-Chun Pei, Chih-Min Liu & Wen-Sung Lai. (2014) Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits. Frontiers in Behavioral Neuroscience 8.
Crossref
Crossref
Paula M. Moran, Colm M.P. O'Tuathaigh, Francesco Papaleo & John L. Waddington. 2014. Dopamine. Dopamine
79
112
.
Dong-Min Yin, Xiang-Dong Sun, Jonathan C. Bean, Thiri W. Lin, Anupama Sathyamurthy, Wen-Cheng Xiong, Tian-Ming Gao, Yong-Jun Chen & Lin Mei. (2013) Regulation of Spine Formation by ErbB4 in PV-Positive Interneurons. The Journal of Neuroscience 33:49, pages 19295-19303.
Crossref
Crossref
Dong-Min Yin, Yong-Jun Chen, Yi-Sheng Lu, Jonathan C. Bean, Anupama Sathyamurthy, Chengyong Shen, Xihui Liu, Thiri W. Lin, Clifford A. Smith, Wen-Cheng Xiong & Lin Mei. (2013) Reversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1. Neuron 78:4, pages 644-657.
Crossref
Crossref
Chao Deng, Bo Pan, Martin Engel & Xu-Feng Huang. (2013) Neuregulin-1 signalling and antipsychotic treatment. Psychopharmacology 226:2, pages 201-215.
Crossref
Crossref
Ketan Marballi, Dianne Cruz, Peter Thompson & Consuelo Walss-Bass. (2012) Differential Neuregulin 1 Cleavage in the Prefrontal Cortex and Hippocampus in Schizophrenia and Bipolar Disorder: Preliminary Findings. PLoS ONE 7:5, pages e36431.
Crossref
Crossref
C S Weickert, Y Tiwari, P R Schofield, B J Mowry & J M Fullerton. (2012) Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Translational Psychiatry 2:4, pages e104-e104.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Psychiatry 25:2, pages 155-162.
Crossref
Crossref
Bo Pan, Xu-Feng Huang & Chao Deng. (2011) Antipsychotic treatment and neuregulin 1–ErbB4 signalling in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:4, pages 924-930.
Crossref
Crossref
N Takahashi, T Sakurai, O Bozdagi-Gunal, N P Dorr, J Moy, L Krug, M Gama-Sosa, G A Elder, R J Koch, R H Walker, P R Hof, K L Davis & J D Buxbaum. (2011) Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Translational Psychiatry 1:5, pages e8-e8.
Crossref
Crossref
Peyman Yeganeh-Doost, Oliver Gruber, Peter Falkai & Andrea Schmitt. (2011) The role of the cerebellum in schizophrenia: from cognition to molecular pathways. Clinics 66, pages 71-77.
Crossref
Crossref